Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure
Not Applicable
Recruiting
- Conditions
- Heart Failure
- Interventions
- Other: HF-guided VAOther: Standard-of-care
- Registration Number
- NCT06400927
- Lead Sponsor
- East and North Hertfordshire NHS Trust
- Brief Summary
The aim of this pilot randomized study is to examine whether integrating the SIRIO-HF virtual assistant (VA) into the outpatient management of participants recently discharged from hospital with a new diagnosis of heart failure (HF), may reduce the need for regular medical assessment and the healthcare burden, reduce variability in healthcare, and meet with participant satisfaction, without compromising participant safety and overall care quality.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Age ≥ 18 years
- Newly diagnosed HF with New York Heart Association class II-III symptoms at discharge
Exclusion Criteria
- Known prior history of HF
- Severe comorbidities that could affect protocol adherence, in the opinion of the investigator
- Alternative diagnosis for symptoms such as chronic obstructive pulmonary disease
- Dementia or other cognitive impairment
- Currently involved in another interventional clinical trial
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description VA-guided arm HF-guided VA - Standard-of-care arm Standard-of-care -
- Primary Outcome Measures
Name Time Method Acceptability of the intervention to users (participants) 12 weeks This will be assessed utilising an adapted 'acceptability of intervention measure' (AIM)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
East and North Hertfordshire NHS Trust
🇬🇧Stevenage, Hertfordshire, United Kingdom